{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T09:05:41Z","timestamp":1794387941227,"version":"4.9.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s43440-024-00613-5","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T14:08:15Z","timestamp":1719324495000},"page":"679-692","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Mechanistic insights on TLR-4 mediated inflammatory pathway in neurodegenerative diseases"],"prefix":"10.1007","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6061-2012","authenticated-orcid":false,"given":"Veerta","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3656-669X","authenticated-orcid":false,"given":"Prateek","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2979-1590","authenticated-orcid":false,"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,25]]},"reference":[{"issue":"3","key":"613_CR1","first-page":"125","volume":"37","author":"AM Smith","year":"2014","unstructured":"Smith AM, Dragunow M. The human side of microglia. TINS. 2014;37(3):125\u201335.","journal-title":"TINS"},{"issue":"2","key":"613_CR2","doi-asserted-by":"publisher","first-page":"649","DOI":"10.4049\/jimmunol.1002302","volume":"186","author":"S Valanne","year":"2011","unstructured":"Valanne S, Wang JH, R\u00e4met M. The Drosophila toll signaling pathway. J Immunol. 2011;186(2):649\u201356.","journal-title":"J Immunol"},{"issue":"5","key":"613_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat immunology. 2010;11(5):373\u201384.","journal-title":"Nat immunology"},{"issue":"11","key":"613_CR4","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1111\/j.1582-4934.2010.01127.x","volume":"14","author":"L Yu","year":"2010","unstructured":"Yu L, Wang L, Chen S. Endogenous toll-like receptor ligands and their biological significance. J Cell Mol Med. 2010;14(11):2592\u2013603.","journal-title":"J Cell Mol Med"},{"issue":"10","key":"613_CR5","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.intimp.2011.05.006","volume":"11","author":"DS Arroyo","year":"2011","unstructured":"Arroyo DS, Soria JA, Gaviglio EA, Rodriguez-Galan MC, Iribarren P. Toll-like receptors are key players in neurodegeneration. Int Immunopharmacol. 2011;11(10):1415\u201321.","journal-title":"Int Immunopharmacol"},{"issue":"129","key":"613_CR6","doi-asserted-by":"publisher","first-page":"110373","DOI":"10.1016\/j.biopha.2020.110373","volume":"1","author":"V Sharma","year":"2020","unstructured":"Sharma V, Kaur A, Singh TG. Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer\u2019s disease. Biomed Pharmacother. 2020;1(129):110373.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"613_CR7","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1093\/brain\/awad150","volume":"146","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, Di Lazzaro G, Marino G, Campanelli F, Ghiglieri V. Advances in understanding the function of alpha-synuclein: implications for Parkinson\u2019s disease. Brain. 2023;146(9):3587\u201397.","journal-title":"Brain"},{"issue":"2","key":"613_CR8","first-page":"129","volume":"5","author":"O Eje","year":"2023","unstructured":"Eje O, Ogbonna CV, Onoyima CS, Nduka FO. Huntington Disease: mechanism of Pathogenesis and recent developments in its therapeutic strategies: a review. J Chem Rev. 2023;5(2):129\u201342.","journal-title":"J Chem Rev"},{"issue":"1","key":"613_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s11033-023-09202-w","volume":"51","author":"V Sharma","year":"2024","unstructured":"Sharma V, Sharma P, Singh TG. Wnt signalling pathways as mediators of neuroprotective mechanisms: therapeutic implications in stroke. Mol Biol Rep. 2024;51(1):247.","journal-title":"Mol Biol Rep"},{"issue":"8","key":"613_CR10","doi-asserted-by":"publisher","first-page":"a024117","DOI":"10.1101\/cshperspect.a024117","volume":"7","author":"LI Grad","year":"2017","unstructured":"Grad LI, Rouleau GA, Ravits J, Cashman NR. Clinical spectrum of amyotrophic lateral sclerosis (ALS). Cold Spring Harb Perspect Med. 2017;7(8):a024117.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"11","key":"613_CR11","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.3389\/fimmu.2020.01588","volume":"26","author":"M Calvo-Rodriguez","year":"2020","unstructured":"Calvo-Rodriguez M, Garc\u00eda-Rodr\u00edguez C, Villalobos C, N\u00fa\u00f1ez L. Role of toll like receptor 4 in Alzheimer\u2019s disease. Front Immunol. 2020;26(11):1588.","journal-title":"Front Immunol"},{"issue":"5","key":"613_CR12","first-page":"269","volume":"34","author":"E Okun","year":"2011","unstructured":"Okun E, Griffioen KJ, Mattson MP. Toll-like receptor signaling in neural plasticity and disease. TINS. 2011;34(5):269\u201381.","journal-title":"TINS"},{"issue":"14","key":"613_CR13","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3389\/fnins.2020.00444","volume":"20","author":"W Cui","year":"2020","unstructured":"Cui W, Sun C, Ma Y, Wang S, Wang X, Zhang Y. Inhibition of TLR4 induces M2 microglial polarization and provides neuroprotection via the NLRP3 inflammasome in Alzheimer\u2019s disease. Front Neurosci. 2020;20(14):444.","journal-title":"Front Neurosci"},{"issue":"9","key":"613_CR14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1042\/CS20110164","volume":"121","author":"ML Hanke","year":"2011","unstructured":"Hanke ML, Kielian T. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin Sci. 2011;121(9):367\u201387.","journal-title":"Clin Sci"},{"issue":"6","key":"613_CR15","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.4049\/jimmunol.173.6.3916","volume":"173","author":"JK Olson","year":"2004","unstructured":"Olson JK, Miller SD. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol. 2004;173(6):3916\u201324.","journal-title":"J Immunol"},{"issue":"1\u20132","key":"613_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2014.01.014","volume":"268","author":"T Trotta","year":"2014","unstructured":"Trotta T, Porro C, Calvello R, Panaro MA. Biological role of Toll-like receptor-4 in the brain. J Neuroimmunol. 2014;268(1\u20132):1\u20132.","journal-title":"J Neuroimmunol"},{"issue":"402","key":"613_CR17","doi-asserted-by":"publisher","first-page":"pe47","DOI":"10.1126\/stke.4022007pe47","volume":"2007","author":"PH Larsen","year":"2007","unstructured":"Larsen PH, Holm TH, Owens T. Toll-like receptors in brain development and homeostasis. Sci STKE. 2007;2007(402):pe47.","journal-title":"Sci STKE"},{"issue":"5","key":"613_CR18","doi-asserted-by":"publisher","first-page":"e37767","DOI":"10.1371\/journal.pone.0037767","volume":"7","author":"D Kaul","year":"2012","unstructured":"Kaul D, Habbel P, Derkow K, Kr\u00fcger C, Franzoni E, Wulczyn FG, et al. Expression of Toll-like receptors in the developing brain. PLoS\u00a0ONE. 2012;7(5):e37767.","journal-title":"PLoS\u00a0ONE"},{"issue":"11","key":"613_CR19","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1093\/jnen\/61.11.1013","volume":"61","author":"M Bsibsi","year":"2002","unstructured":"Bsibsi M, Ravid R, Gveric D, van Noort JM. Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol. 2002;61(11):1013\u201321.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"613_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1471-4159.2010.06736.x","volume":"114","author":"MM Buchanan","year":"2010","unstructured":"Buchanan MM, Hutchinson M, Watkins LR, Yin H. Toll-like receptor 4 in CNS pathologies. J Neurochem. 2010;114(1):13\u201327.","journal-title":"J Neurochem"},{"issue":"6","key":"613_CR21","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.molcel.2014.08.006","volume":"55","author":"R Ferrao","year":"2014","unstructured":"Ferrao R, Zhou H, Shan Y, Liu Q, Li Q, Shaw DE, et al. IRAK4 dimerization and trans-autophosphorylation are induced by Myddosome assembly. Mol Cell. 2014;55(6):891\u2013903.","journal-title":"Mol Cell"},{"issue":"11","key":"613_CR22","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","volume":"13","author":"T Kawai","year":"2007","unstructured":"Kawai T, Akira S. Signaling to NF-\u03baB by Toll-like receptors. Trends Mol Med. 2007;13(11):460\u20139.","journal-title":"Trends Mol Med"},{"issue":"2","key":"613_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.biopha.2008.01.003","volume":"63","author":"Z Li","year":"2009","unstructured":"Li Z, Xia X, Zhang S, Zhang A, Bo W, Zhou R. Up-regulation of Toll-like receptor 4 was suppressed by emodin and baicalin in the setting of acute pancreatitis. Biomed Pharmacother. 2009;63(2):120\u20138.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"613_CR24","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1074\/jbc.M113.521161","volume":"289","author":"I Guijarro-Mu\u00f1oz","year":"2014","unstructured":"Guijarro-Mu\u00f1oz I, Compte M, \u00c1lvarez-Cienfuegos A, \u00c1lvarez-Vallina L, Sanz L. Lipopolysaccharide activates Toll-like receptor 4 (TLR4)-mediated NF-\u03baB signaling pathway and proinflammatory response in human pericytes. J Biol Chem. 2014;289(4):2457\u201368.","journal-title":"J Biol Chem"},{"issue":"6","key":"613_CR25","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140(6):805\u201320.","journal-title":"Cell"},{"key":"613_CR26","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1007\/s00018-010-0464-x","volume":"67","author":"R Ostuni","year":"2010","unstructured":"Ostuni R, Zanoni I, Granucci F. Deciphering the complexity of Toll-like receptor signaling. Cell Mol Life Sci. 2010;67:4109\u201334.","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"613_CR27","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.4049\/jimmunol.171.8.3977","volume":"171","author":"H Nagase","year":"2003","unstructured":"Nagase H, Okugawa S, Ota Y, Yamaguchi M, Tomizawa H, Matsushima K, et al. Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand. J Immunol. 2003;171(8):3977\u201382.","journal-title":"J Immunol"},{"issue":"3","key":"613_CR28","doi-asserted-by":"publisher","first-page":"249","DOI":"10.21307\/ane-2021-023","volume":"81","author":"A Heidari","year":"2021","unstructured":"Heidari A, Rostam-Abadi Y, Rezaei N. The immune system and autism spectrum disorder: association and therapeutic challenges. Acta Neurobiol Exp. 2021;81(3):249\u201363.","journal-title":"Acta Neurobiol Exp"},{"issue":"3","key":"613_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nri.2016.144","volume":"17","author":"T Korn","year":"2017","unstructured":"Korn T, Kallies A. T cell responses in the central nervous system. Nat Rev Immunol. 2017;17(3):179\u201394.","journal-title":"Nat Rev Immunol"},{"issue":"332","key":"613_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jneuroim.2019.03.012","volume":"15","author":"V Kumar","year":"2019","unstructured":"Kumar V. Toll-like receptors in the pathogenesis of neuroinflammation. J Neuroimmunol. 2019;15(332):16\u201330.","journal-title":"J Neuroimmunol"},{"issue":"7","key":"613_CR31","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1086\/591626","volume":"198","author":"M Klein","year":"2008","unstructured":"Klein M, Obermaier B, Angele B, Pfister HW, Wagner H, Koedel U, et al. Innate immunity to pneumococcal infection of the central nervous system depends on toll-like receptor (TLR) 2 and TLR4. J Infect Dis. 2008;198(7):1028\u201336.","journal-title":"J Infect Dis"},{"issue":"1","key":"613_CR32","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/JAD-2010-1221","volume":"19","author":"MP Murphy","year":"2010","unstructured":"Murphy MP, LeVine H III. Alzheimer\u2019s disease and the amyloid-\u03b2 peptide. J Alzheimers Dis. 2010;19(1):311\u201323.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"613_CR33","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.4049\/jimmunol.1101121","volume":"188","author":"S Liu","year":"2012","unstructured":"Liu S, Liu Y, Hao W, Wolf L, Kiliaan AJ, Penke B, et al. TLR2 is a primary receptor for Alzheimer\u2019s amyloid \u03b2 peptide to trigger neuroinflammatory activation. J Immunol. 2012;188(3):1098\u2013107.","journal-title":"J Immunol"},{"issue":"2","key":"613_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2174\/157015907780866893","volume":"5","author":"NN Inamdar","year":"2007","unstructured":"Inamdar NN, Arulmozhi DK, Tandon A, Bodhankar SL. Parkinson\u2019s disease: genetics and beyond. Curr Neuropharmacol. 2007;5(2):99\u2013113.","journal-title":"Curr Neuropharmacol"},{"issue":"81","key":"613_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbi.2019.06.042","volume":"1","author":"A Kouli","year":"2019","unstructured":"Kouli A, Horne CB, Williams-Gray CH. Toll-like receptors and their therapeutic potential in Parkinson\u2019s disease and \u03b1-synucleinopathies. Brain Behav Immun. 2019;1(81):41\u201351.","journal-title":"Brain Behav Immun"},{"issue":"3","key":"613_CR36","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1161\/hs0302.103740","volume":"33","author":"RM Cowell","year":"2002","unstructured":"Cowell RM, Xu H, Galasso JM, Silverstein FS. Hypoxic-ischemic injury induces macrophage inflammatory protein-1\u03b1 expression in immature rat brain. Stroke. 2002;33(3):795\u2013801.","journal-title":"Stroke"},{"issue":"140","key":"613_CR37","doi-asserted-by":"publisher","first-page":"111729","DOI":"10.1016\/j.biopha.2021.111729","volume":"1","author":"AK Grewal","year":"2021","unstructured":"Grewal AK, Singh TG, Sharma D, Sharma V, Singh M, Rahman MH, et al. Mechanistic insights and perspectives involved in neuroprotective action of quercetin. Biomed Pharmacother. 2021;1(140):111729.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"613_CR38","doi-asserted-by":"publisher","first-page":"e00508","DOI":"10.1016\/j.heliyon.2018.e00508","volume":"4","author":"K Griffioen","year":"2018","unstructured":"Griffioen K, Mattson MP, Okun E. Deficiency of Toll-like receptors 2, 3 or 4 extends life expectancy in Huntington\u2019s disease mice. Heliyon. 2018;4(1):e00508.","journal-title":"Heliyon"},{"issue":"27","key":"613_CR39","doi-asserted-by":"publisher","first-page":"11263","DOI":"10.1073\/pnas.0704307104","volume":"104","author":"L Banci","year":"2007","unstructured":"Banci L, Bertini I, Durazo A, Girotto S, Gralla EB, Martinelli M, et al. Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: a possible general mechanism for familial ALS. Proc Natl Acad Sci. 2007;104(27):11263\u20137.","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"613_CR40","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.1109\/TAC.2021.3124193","volume":"67","author":"TJ Arnold","year":"2021","unstructured":"Arnold TJ, Rawlings JB. Tractable calculation and estimation of the optimal weighting matrix for ALS problems. IEEE Trans Automatic Control. 2021;67(11):6045\u201352.","journal-title":"IEEE Trans Automatic Control"},{"issue":"179","key":"613_CR41","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.neuroscience.2011.02.001","volume":"14","author":"M Casula","year":"2011","unstructured":"Casula M, Iyer AM, Spliet WG, Anink JJ, Steentjes K, Sta M, et al. Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissue. Neuroscience. 2011;14(179):233\u201343.","journal-title":"Neuroscience"},{"issue":"10","key":"613_CR42","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.intimp.2011.04.025","volume":"11","author":"Y Kong","year":"2011","unstructured":"Kong Y, Le Y. Toll-like receptors in inflammation of the central nervous system. Int Immunopharmacol. 2011;11(10):1407\u201314.","journal-title":"Int Immunopharmacol"},{"issue":"18","key":"613_CR43","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/S1353-8020(11)70008-6","volume":"1","author":"D B\u00e9raud","year":"2012","unstructured":"B\u00e9raud D, Maguire-Zeiss KA. Misfolded \u03b1-synuclein and toll-like receptors: therapeutic targets for Parkinson\u2019s disease. Parkinsonism Relat Disord. 2012;1(18):S17-20.","journal-title":"Parkinsonism Relat Disord"},{"issue":"376","key":"613_CR44","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1126\/scisignal.2005965","volume":"8","author":"SG Daniele","year":"2015","unstructured":"Daniele SG, B\u00e9raud D, Davenport C, Cheng K, Yin H, Maguire-Zeiss KA. Activation of MyD88-dependent TLR1\/2 signaling by misfolded \u03b1-synuclein, a protein linked to neurodegenerative disorders. Sci Signal. 2015;8(376):45.","journal-title":"Sci Signal"},{"key":"613_CR45","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s12035-012-8340-3","volume":"47","author":"L Fellner","year":"2013","unstructured":"Fellner L, Stefanova N. The role of glia in alpha-synucleinopathies. Mol Neurobiol. 2013;47:575\u201386.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"613_CR46","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1038\/srep01393","volume":"3","author":"C Noelker","year":"2013","unstructured":"Noelker C, Morel L, Lescot T, Osterloh A, Alvarez-Fischer D, Breloer M, et al. Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease. Sci Rep. 2013;3(1):1393.","journal-title":"Sci Rep"},{"issue":"223","key":"613_CR47","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.lfs.2019.03.030","volume":"15","author":"R Lv","year":"2019","unstructured":"Lv R, Du L, Liu X, Zhou F, Zhang Z, Zhang L. Rosmarinic acid attenuates inflammatory responses through inhibiting HMGB1\/TLR4\/NF-\u03baB signaling pathway in a mouse model of Parkinson\u2019s disease. Life Sci. 2019;15(223):158\u201365.","journal-title":"Life Sci"},{"issue":"11","key":"613_CR48","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3389\/fphar.2020.00776","volume":"26","author":"P Gan","year":"2020","unstructured":"Gan P, Ding L, Hang G, Xia Q, Huang Z, Ye X, Qian X. Oxymatrine attenuates dopaminergic neuronal damage and microglia-mediated neuroinflammation through cathepsin D-dependent HMGB1\/TLR4\/NF-\u03baB pathway in Parkinson\u2019s disease. Front Pharmacol. 2020;26(11):776.","journal-title":"Front Pharmacol"},{"issue":"87","key":"613_CR49","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neuro.2021.08.018","volume":"1","author":"Q Li","year":"2021","unstructured":"Li Q, Zhang P, Cai Y. Genkwanin suppresses MPP+-induced cytotoxicity by inhibiting TLR4\/MyD88\/NLRP3 inflammasome pathway in a cellular model of Parkinson\u2019s disease. Neurotoxicology. 2021;1(87):62\u20139.","journal-title":"Neurotoxicology"},{"issue":"11","key":"613_CR50","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.3390\/biomedicines10112929","volume":"10","author":"IU Rehman","year":"2022","unstructured":"Rehman IU, Khan A, Ahmad R, Choe K, Park HY, Lee HJ, et al. Neuroprotective effects of nicotinamide against MPTP-induced Parkinson\u2019s disease in mice: impact on oxidative stress, neuroinflammation, Nrf2\/HO-1 and TLR4 signaling pathways. Biomedicines. 2022;10(11):2929.","journal-title":"Biomedicines"},{"issue":"75","key":"613_CR51","doi-asserted-by":"publisher","first-page":"104274","DOI":"10.1016\/j.jff.2020.104274","volume":"1","author":"Y Sun","year":"2020","unstructured":"Sun Y, Huang WM, Tang PC, Zhang X, Zhang XY, Yu BC, et al. Neuroprotective effects of natural Cordycepin on LPS-induced Parkinson\u2019s disease through suppressing TLR4\/NF-\u03baB\/NLRP3-mediated pyroptosis. J Funct Foods. 2020;1(75):104274.","journal-title":"J Funct Foods"},{"issue":"15","key":"613_CR52","first-page":"6956","volume":"27","author":"XL Liu","year":"2023","unstructured":"Liu XL, Fan L, Yue BH, Lou Z (2023) Saikosaponin A mitigates the progression of Parkinson\u2019s disease via attenuating microglial neuroinflammation through TLR4\/MyD88\/NF-\u03baB pathway. Eur Rev Med Pharmacol Sci 27(15):6956\u20136971","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"613_CR53","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3390\/ma15030804","volume":"15","author":"T Bhattacharya","year":"2022","unstructured":"Bhattacharya T, Soares GA, Chopra H, Rahman MM, Hasan Z, Swain SS, et al. Applications of phyto-nanotechnology for the treatment of neurodegenerative disorders. Materials. 2022;15(3):804.","journal-title":"Materials"},{"issue":"10","key":"613_CR54","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1080\/14728222.2019.1676416","volume":"23","author":"GR Leitner","year":"2019","unstructured":"Leitner GR, Wenzel TJ, Marshall N, Gates EJ, Klegeris A. Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders. Expert Opin Ther Targets. 2019;23(10):865\u201382.","journal-title":"Expert Opin Ther Targets"},{"issue":"6","key":"613_CR55","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.2174\/1570159X19666211201094608","volume":"20","author":"J Saba","year":"2022","unstructured":"Saba J, Couselo FL, Bruno J, Carniglia L, Durand D, Lasaga M, et al. Neuroinflammation in Huntington\u2019s disease: A starring role for astrocyte and microglia. Curr Neuropharmacol. 2022;20(6):1116.","journal-title":"Curr Neuropharmacol"},{"issue":"314","key":"613_CR56","doi-asserted-by":"publisher","first-page":"121317","DOI":"10.1016\/j.lfs.2022.121317","volume":"1","author":"AM Gendy","year":"2023","unstructured":"Gendy AM, El-Sadek HM, Amin MM, Ahmed KA, El-Sayed MK, El-Haddad AE, et al. Glycyrrhizin prevents 3-nitropropionic acid-induced neurotoxicity by downregulating HMGB1\/TLR4\/NF-\u03baB p65 signaling, and attenuating oxidative stress, inflammation, and apoptosis in rats. Life Sci. 2023;1(314):121317.","journal-title":"Life Sci"},{"issue":"9","key":"613_CR57","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/s41401-020-00558-4","volume":"42","author":"X Yang","year":"2021","unstructured":"Yang X, Chu SF, Wang ZZ, Li FF, Yuan YH, Chen NH. Ginsenoside Rg1 exerts neuroprotective effects in 3-nitropronpionic acid-induced mouse model of Huntington\u2019s disease via suppressing MAPKs and NF-\u03baB pathways in the striatum. Acta Pharmacol Sin. 2021;42(9):1409\u201321.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"613_CR58","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1038\/s41467-019-11441-0","volume":"10","author":"JJ Siew","year":"2019","unstructured":"Siew JJ, Chen HM, Chen HY, Chen HL, Chen CM, Soong BW, et al. Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington\u2019s disease. Nat Commun. 2019;10(1):3473.","journal-title":"Nat Commun"},{"issue":"1","key":"613_CR59","first-page":"5521519","volume":"2021","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhang B, Liu J, Qiao C, Xue N, Lv H, Li S, Mogroside V. Alleviates lipopolysaccharide-induced neuroinflammation via inhibition of TLR4-MyD88 and activation of AKT\/AMPK-Nrf2 signaling pathway. Evid-Based Complement Altern Med. 2021;2021(1):5521519.","journal-title":"Evid-Based Complement Altern Med"},{"issue":"12","key":"613_CR60","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.3390\/molecules26123724","volume":"26","author":"T Behl","year":"2021","unstructured":"Behl T, Kaur D, Sehgal A, Singh S, Sharma N, Zengin G, et al. Role of monoamine oxidase activity in Alzheimer\u2019s disease: an insight into the therapeutic potential of inhibitors. Molecules. 2021;26(12):3724.","journal-title":"Molecules"},{"issue":"7","key":"613_CR61","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.jalz.2019.03.012","volume":"15","author":"J Miron","year":"2019","unstructured":"Miron J, Picard C, Lafaille-Magnan M\u00c9, Savard M, Labont\u00e9 A, Breitner J, PREVENT-AD research group, et al. Association of TLR4 with Alzheimer\u2019s disease risk and presymptomatic biomarkers of inflammation. Alzheimer\u2019s Dement. 2019;15(7):951\u201360.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"3","key":"613_CR62","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.neulet.2005.08.047","volume":"391","author":"P Minoretti","year":"2006","unstructured":"Minoretti P, Gazzaruso C, Di Vito C, Emanuele E, Bianchi M, Coen E, et al. Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer\u2019s disease. Neurosci Lett. 2006;391(3):147\u20139.","journal-title":"Neurosci Lett"},{"issue":"56","key":"613_CR63","doi-asserted-by":"publisher","first-page":"6293","DOI":"10.1007\/s12035-019-1512-7","volume":"15","author":"M Ikram","year":"2019","unstructured":"Ikram M, Muhammad T, Rehman SU, Khan A, Jo MG, Ali T, et al. Hesperetin confers neuroprotection by regulating Nrf2\/TLR4\/NF-\u03baB signaling in an A\u03b2 mouse model. Mol Neurobiol. 2019;15(56):6293\u2013309.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"613_CR64","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/eji.201545855","volume":"46","author":"S Shi","year":"2016","unstructured":"Shi S, Liang D, Chen Y, Xie Y, Wang Y, Wang L, et al. Gx-50 reduces \u03b2-amyloid-induced TNF-\u03b1, IL-1\u03b2, NO, and PGE2 expression and inhibits NF-\u03baB signaling in a mouse model of Alzheimer\u2019s disease. Eur J Immunol. 2016;46(3):665\u201376.","journal-title":"Eur J Immunol"},{"issue":"346","key":"613_CR65","doi-asserted-by":"publisher","first-page":"577284","DOI":"10.1016\/j.jneuroim.2020.577284","volume":"15","author":"MF Guo","year":"2020","unstructured":"Guo MF, Zhang HY, Li YH, Gu QF, Wei WY, Wang YY, et al. Fasudil inhibits the activation of microglia and astrocytes of transgenic Alzheimer\u2019s disease mice via the downregulation of TLR4\/Myd88\/NF-\u03baB pathway. J Neuroimmunol. 2020;15(346):577284.","journal-title":"J Neuroimmunol"},{"issue":"90","key":"613_CR66","doi-asserted-by":"publisher","first-page":"153627","DOI":"10.1016\/j.phymed.2021.153627","volume":"1","author":"D Ren","year":"2021","unstructured":"Ren D, Fu Y, Wang L, Liu J, Zhong X, Yuan J, et al. Tetrandrine ameliorated Alzheimer\u2019s disease through suppressing microglial inflammatory activation and neurotoxicity in the 5XFAD mouse. Phytomedicine. 2021;1(90):153627.","journal-title":"Phytomedicine"},{"issue":"869","key":"613_CR67","doi-asserted-by":"publisher","first-page":"172857","DOI":"10.1016\/j.ejphar.2019.172857","volume":"15","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Hou J, Mo Y, Ren M, Yang G, Qu Z, et al. Geniposidic acid ameliorates spatial learning and memory deficits and alleviates neuroinflammation via inhibiting HMGB-1 and downregulating TLR4\/2 signaling pathway in APP\/PS1 mice. Eur J Pharmacol. 2020;15(869):172857.","journal-title":"Eur J Pharmacol"},{"issue":"83","key":"613_CR68","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ijbiomac.2015.11.011","volume":"1","author":"S Jia","year":"2016","unstructured":"Jia S, Lu Z, Gao Z, An J, Wu X, Li X, et al. Chitosan oligosaccharides alleviate cognitive deficits in an amyloid-\u03b21\u201342-induced rat model of Alzheimer\u2019s disease. Int J Biol Macromol. 2016;1(83):416\u201325.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"613_CR69","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1080\/13880209.2020.1809462","volume":"58","author":"Z Wang","year":"2020","unstructured":"Wang Z, Chen Z, Li B, Zhang B, Du Y, Liu Y, et al. Curcumin attenuates renal interstitial fibrosis of obstructive nephropathy by suppressing epithelial-mesenchymal transition through inhibition of the TLR4\/NF-\u043aB and PI3K\/AKT signalling pathways. Pharm Biol. 2020;58(1):828\u201337.","journal-title":"Pharm Biol"},{"issue":"1","key":"613_CR70","first-page":"2859135","volume":"2018","author":"M Molteni","year":"2018","unstructured":"Molteni M, Bosi A, Rossetti C. Natural products with toll-like receptor 4 antagonist activity. Int J Inflamm. 2018;2018(1):2859135.","journal-title":"Int J Inflamm"},{"issue":"60","key":"613_CR71","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.bbi.2016.10.012","volume":"1","author":"C Balducci","year":"2017","unstructured":"Balducci C, Frasca A, Zotti M, La Vitola P, Mhillaj E, Grigoli E, et al. Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by \u03b2-amyloid oligomers in an acute mouse model of Alzheimer\u2019s disease. Brain Behav Immun. 2017;1(60):188\u201397.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"613_CR72","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s42003-020-0792-9","volume":"3","author":"C Hughes","year":"2020","unstructured":"Hughes C, Choi ML, Yi JH, Kim SC, Drews A, George-Hyslop PS, et al. Beta amyloid aggregates induce sensitised TLR4 signalling causing long-term potentiation deficit and rat neuronal cell death. Commun Biol. 2020;3(1):79.","journal-title":"Commun Biol"},{"issue":"3","key":"613_CR73","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.neuropharm.2008.01.005","volume":"55","author":"KP Doyle","year":"2008","unstructured":"Doyle KP, Simon RP, Stenzel-Poore MP. Mechanisms of ischemic brain damage. Neuropharmacology. 2008;55(3):310\u20138.","journal-title":"Neuropharmacology"},{"issue":"12","key":"613_CR74","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1111\/j.1365-2702.2007.02156.x","volume":"17","author":"Y Qiu","year":"2008","unstructured":"Qiu Y, Li S. Stroke: coping strategies and depression among Chinese caregivers of survivors during hospitalisation. J Clin Nurs. 2008;17(12):1563\u201373.","journal-title":"J Clin Nurs"},{"issue":"5","key":"613_CR75","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/NEN.0000000000000068","volume":"73","author":"R Gesuete","year":"2014","unstructured":"Gesuete R, Kohama SG, Stenzel-Poore MP. Toll-like receptors and ischemic brain injury. J Neuropathol Exp Neurol. 2014;73(5):378\u201386.","journal-title":"J Neuropathol Exp Neurol"},{"key":"613_CR76","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1471-4159.2012.07941.x","volume":"123","author":"T Shichita","year":"2012","unstructured":"Shichita T, Ago T, Kamouchi M, Kitazono T, Yoshimura A, Ooboshi H. Novel therapeutic strategies targeting innate immune responses and early inflammation after stroke. J Neurochem. 2012;123:29\u201338.","journal-title":"J Neurochem"},{"key":"613_CR77","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11064-013-1194-x","volume":"39","author":"L Wang","year":"2014","unstructured":"Wang L, Li Z, Zhang X, Wang S, Zhu C, Miao J, et al. Protective effect of shikonin in experimental ischemic stroke: attenuated TLR4, p-p38MAPK, NF-\u03baB, TNF-\u03b1 and MMP-9 expression, up-regulated claudin-5 expression, ameliorated BBB permeability. Neurochem Res. 2014;39:97\u2013106.","journal-title":"Neurochem Res"},{"issue":"1","key":"613_CR78","doi-asserted-by":"publisher","first-page":"11445","DOI":"10.1038\/srep11445","volume":"5","author":"M Sun","year":"2015","unstructured":"Sun M, Deng B, Zhao X, Gao C, Yang L, Zhao H, et al. Isoflurane preconditioning provides neuroprotection against stroke by regulating the expression of the TLR4 signalling pathway to alleviate microglial activation. Sci Rep. 2015;5(1):11445.","journal-title":"Sci Rep"},{"issue":"1","key":"613_CR79","first-page":"660","volume":"17","author":"S Zhu","year":"2018","unstructured":"Zhu S, Tang S, Su F. Dioscin inhibits ischemic stroke-induced inflammation through inhibition of the TLR4\/MyD88\/NF-\u03baB signaling pathway in a rat model. Mol Med Rep. 2018;17(1):660\u20136.","journal-title":"Mol Med Rep"},{"issue":"253","key":"613_CR80","doi-asserted-by":"publisher","first-page":"112616","DOI":"10.1016\/j.jep.2020.112616","volume":"10","author":"Y Li","year":"2020","unstructured":"Li Y, Liang W, Guo C, Chen X, Huang Y, Wang H, et al. Renshen Shouwu extract enhances neurogenesis and angiogenesis via inhibition of TLR4\/NF-\u03baB\/NLRP3 signaling pathway following ischemic stroke in rats. J Ethnopharmacol. 2020;10(253):112616.","journal-title":"J Ethnopharmacol"},{"issue":"237","key":"613_CR81","doi-asserted-by":"publisher","first-page":"116915","DOI":"10.1016\/j.lfs.2019.116915","volume":"15","author":"X Tian","year":"2019","unstructured":"Tian X, Liu H, Xiang F, Xu L, Dong Z. \u03b2-Caryophyllene protects against ischemic stroke by promoting polarization of microglia toward M2 phenotype via the TLR4 pathway. Life Sci. 2019;15(237):116915.","journal-title":"Life Sci"},{"issue":"1528","key":"613_CR82","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.brainres.2013.06.032","volume":"28","author":"J Zhang","year":"2013","unstructured":"Zhang J, Fu B, Zhang X, Chen L, Zhang L, Zhao X, et al. Neuroprotective effect of bicyclol in rat ischemic stroke: down-regulates TLR4, TLR9, TRAF6, NF-\u03baB, MMP-9 and up-regulates claudin-5 expression. Brain Res. 2013;28(1528):80\u20138.","journal-title":"Brain Res"},{"issue":"1","key":"613_CR83","first-page":"9938874","volume":"2021","author":"J Zhang","year":"2021","unstructured":"Zhang J, Jiang H, Wu F, Chi X, Pang Y, Jin H, Sun Y, Zhang S. Neuroprotective effects of hesperetin in regulating microglia polarization after ischemic stroke by inhibiting TLR4\/NF-\u03baB pathway. J Healthc Eng. 2021;2021(1):9938874.","journal-title":"J Healthc Eng"},{"issue":"6","key":"613_CR84","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1083\/jcb.200705046","volume":"179","author":"J Kang","year":"2007","unstructured":"Kang J, Rivest S. MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis. J Cell Biol. 2007;179(6):1219\u201330.","journal-title":"J Cell Biol"},{"issue":"5","key":"613_CR85","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.bbi.2010.12.008","volume":"25","author":"DR Beers","year":"2011","unstructured":"Beers DR, Zhao W, Liao B, Kano O, Wang J, Huang A, et al. Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice. Brain Behav Immun. 2011;25(5):1025\u201335.","journal-title":"Brain Behav Immun"},{"issue":"02","key":"613_CR86","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1142\/S0192415X16500233","volume":"44","author":"M Cai","year":"2016","unstructured":"Cai M, Yang EJ. Ginsenoside Re attenuates neuroinflammation in a symptomatic ALS animal model. Am J Chin Med. 2016;44(02):401\u201313.","journal-title":"Am J Chin Med"},{"issue":"1","key":"613_CR87","doi-asserted-by":"crossref","first-page":"8580152","DOI":"10.1155\/2018\/8580152","volume":"2018","author":"S Park","year":"2018","unstructured":"Park S, Yang EJ. Anti-inflammatory effect of gamisoyo-san in an animal model of amyotrophic lateral sclerosis. Evid Based Complement Alternat Med. 2018;2018(1):8580152.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"613_CR88","first-page":"1893526","volume":"2019","author":"SH Lee","year":"2019","unstructured":"Lee SH, Yang EJ. Anti-neuroinflammatory effect of jaeumganghwa-tang in an animal model of amyotrophic lateral sclerosis. Evid Based Complement Alternat Med. 2019;2019(1):1893526.","journal-title":"Evid Based Complement Alternat Med"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-024-00613-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-024-00613-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-024-00613-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T12:57:37Z","timestamp":1732280257000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-024-00613-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":88,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["613"],"URL":"https:\/\/doi.org\/10.1007\/s43440-024-00613-5","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,25]]},"assertion":[{"value":"6 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}